Tumor capsule-related single nucleotide polymorphisms in hepatocellular carcinoma.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029264

Enrollment

Unknown

Registered

2020-01-20

Start date

2020-02-01

Completion date

Unknown

Last updated

2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocelluar carcinoma

Interventions

Tumor capsule group:None

No tumor capsule group :?

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Diagnosis as hepatocellular carcinoma; 3. With no history of treatments on hepatocellular carcinoma; 4. With chronic hepatitis B; 5. Child-Pugh Class A-B; 6. ECOG score of 0-1; 7. Be able to undergo the examination of contrast-enhanced CT or MRI.

Exclusion criteria

Exclusion criteria: With history of other tumors; Expected survival time < 3 months.

Design outcomes

Primary

Measure	Time frame
SNPs in BRAF gene;SNPs in TGFß gene;SNPs in MUC15 gene;SNPs in MT1-MMP gene;SNPs in MT1-MMP gene;CD97????SNP??;SNPs in SMYD3 gene;	—

Countries

China

Contacts

Public ContactLi Wei

Beijing Ditan Hospital, Capital Medical University

vision988@126.com+86 010-84322856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026